Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients
ConditionGastrointestinal System Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorArtvin Coruh University
About this trial
This study will investigate whether using a stress ball during chemotherapy can reduce anxiety, fear, and changes in vital signs in patients with gastrointestinal system cancers.
Patients receiving chemotherapy for gastrointestinal cancers often experience anxiety and fear, which may affect their heart rate, blood pressure, and breathing. A stress ball is a simple, low-cost, and safe method that may help patients relax during treatment.
In this randomized controlled study, 60 patients receiving chemotherapy will be assigned to either a stress ball group or a routine care group. Patients in the stress ball group will squeeze a stress ball for 15 minutes during their chemotherapy session. Anxiety, fear levels, and vital signs will be measured before and after chemotherapy in both groups.
The results of this study may help determine whether stress ball use is an effective non-drug method to improve emotional well-being and physiological stability in patients undergoing chemotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being aged 18 years or older
Having a diagnosis of gastrointestinal system cancer and receiving chemotherapy
Having no communication problems
Having no physical disability that would prevent squeezing a stress ball
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Stress Ball
BehavioralThe intervention consists of guided stress ball squeezing during chemotherapy. A round, medium-firm, compressible stress ball approximately 5-6 cm in diameter will be provided to participants. Starting at the beginning of the chemotherapy session, participants will squeeze the stress ball continuously for 15 minutes. They will be instructed to inhale while squeezing the ball, exhale while releasing their grip, and focus their attention on the squeezing activity. Disposable gloves will be used to maintain hygiene during the intervention. No additional behavioral or pharmacological interventions will be applied.
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Stress Ball InterventionExperimental treatment 1 intervention
Group B: Routine Care ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
State Anxiety (STAI-State) score
Time frame
Baseline (before chemotherapy session) and immediately after chemotherapy sessionSecondary outcomes
1
Fear Severity (VAS-Fear)
Fear severity will be measured using a Visual Analog Scale (VAS-Fear). The change in scores before and after chemotherapy will be evaluated to assess the effect of the intervention on fear.
Time frame
Baseline (before chemotherapy session) and immediately after chemotherapy session2
Systolic Blood Pressure
Systolic blood pressure measured using an automatic sphygmomanometer.
Time frame
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.3
Diastolic Blood Pressure
Diastolic blood pressure measured using an automatic sphygmomanometer.
Time frame
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.4
Heart Rate (Pulse)
Heart rate measured in beats per minute using an pulse oximeter
Time frame
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov